my opinion, and that's all it is, an opinion....
I would seriousely doubt Ridgeback would be contemplating selling at this stage.......
Their stated strategy is to invest in research companies that are pursuing unmet diseases as a long term investor...
Off coarse they could be converting warrents but I'm in Vivo's camp here, why would they at depressed prices unless they had to?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $350.4M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $196.2K | 810.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 260204 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 132678 | 2 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |